- 1.
- [ ] (UMLS (ICD9CM) C0730521) Less than 24 completed weeks of gestation =Finding
| - 51. coal mining
- [ ] (UMLS (CSP) C0009133) =Occupational Activity
|
- 2. *Coefficient
- [A constant number that serves as a measure of some property or characteristic. ( NCI )] (UMLS (HL7) C1707429) Coefficient =Quantitative Concept ;
=Kind of quantity;
| - 52. Coast Miwok
- (UMLS (HL7) C1551928) =Language =WesternMiwok;
|
- 3. *Constant
- (UMLS (HL7) C1547014) =Quantitative Concept =Kind of quantity;
| - 53. coastal water
- [ ] (UMLS (CSP) C0442542) =Geographic Area ;
|
- 4. 24 COMP WEEKS GESTATION
- [ ] (UMLS (ICD9CM) C0730522) 24 completed weeks of gestation =Finding
| - 54. coat (enveloped virus)
- [outermost layer of protein, lipid, and glycoconjugates surrounding the nucleocapsid of complex viruses. ( CSP )] (UMLS (CSP) C0178887) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=virus morphology;
|
- 5. 25-26 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135242) 25-26 completed weeks of gestation;
=Temporal Concept | - 55. Coated Particles Tablet
- (UMLS (HL7) C1553202) =Biomedical or Dental Material =Oral Tablet;
|
- 6. 27-28 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135243) 27-28 completed weeks of gestation;
=Temporal Concept | - 56. Coated Pit
- [Specialized depressions on the cell surface involved in receptor-mediated endocytosis; the visible proteinaceous layer on the cytosolic side of the depression provides the coated appearance. ( NCI )] (UMLS (NCI) C0598180) =Cell Component
|
- 7. 29-30 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135244) 29-30 completed weeks of gestation;
=Temporal Concept | - 57. Coated Tablet Dosage Form
- [A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI) ( NCI )] (UMLS (NCI) C1273642) Coated Tablet Dose Form;
TAB COATED;
TABLET, COATED =Biomedical or Dental Material |
- 8. 31-32 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135245) 31-32 completed weeks of gestation;
=Temporal Concept | - 58. Coated Vesicle
- [Vesicles formed when cell-membrane coated pits (COATED PITS, CELL-MEMBRANE) invaginate and pinch off. The outer surface of these vesicles are covered with a lattice-like network of coat proteins, such as CLATHRIN, coat protein complex proteins, or CAVEOLINS. ( MSH )] (UMLS (NCI) C0242915) =Cell Component ;
|
- 9. 33-34 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135246) 33-34 completed weeks of gestation;
=Temporal Concept | - 59. coating
- [FDA label coating ( HL7V3.0 )] (UMLS (HL7) C1552080) =Intellectual Product =FDALabelData;
|
- 10. 35-36 COMP WKS GESTATION
- [ ] (UMLS (ICD9CM) C1135247) 35-36 completed weeks of gestation;
=Temporal Concept | - 60. coating
- [ Definition: A characteristic of an oral solid dosage form of a medicinal product, indicating whether it has one or more coatings such as sugar coating, film coating, or enteric coating. Only coatings to the external surface or the dosage form should be considered (for example, coatings to individual pellets or granules inside a capsule or tablet are excluded from consideration). Constraints: The Observation.value must be a Boolean (BL) with true for the presence or false for the absence of one or more coatings on a solid dosage form. ( HL7V3.0 )] (UMLS (HL7) C1697272) =Intellectual Product =ActCode;
|
- 11. 9,11-Conjugated Linoleic Acid
- [A slightly altered form of linoleic acid, which is an omega-6 fatty acid important to human health. It is found in beef and dairy fats. ( NCI )] (UMLS (NCI) C0050156) =Lipid ;
| - 61. cobalt 60
- [A radioactive form of the metal cobalt, which is used as a source of radiation to treat cancer. ( NCI )] (UMLS (NCI) C0303395) =Element, Ion, or Isotope
|
- 12. C22orf19
- [Identified as a novel Fms-interacting protein. Overexpression in a bipotential myeloid progenitor cell line prevented M-CSF induced macrophage differentiation. Instead, cells differentiated into granulocytes. Thus, appears to have an effect on lineage commitment. (from Oncogene 1999;18:6488-95) ( NCI )] (UMLS (NCI) C1334876) Chromosome 22 Open Reading Frame 19 =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 62. Cobalt Monosulfate Heptahydrate
- (UMLS (NCI) C0891288) Cobalt Sulfate Heptahydrate;
Cobalt Sulfate, 7-Hydrate;
Cobalt(II) Sulfate Heptahydrate;
Sulfuric Acid, Cobalt (2+) Salt (1:1) Heptahydrate;
=Pharmacologic Substance; Inorganic Chemical |
- 13. C6orf49
- [This gene plays a role in cancer differentiation. ( NCI )] (UMLS (NCI) C1332658) C6orf49 Gene;
Chromosome 6 Open Reading Frame 49 Gene =Gene or Genome ;
| - 63. Cobalt Sulfate
- [A reddish, toxic, metallic salt. Cobalt sulfate is used in the electrochemical industries, as a drier in paints and inks, as a coloring agent, in storage batteries and as a supplement for Vitamin B12 deficiency. Exposure to cobalt sulfate results in irritation of the skin, eyes and respiratory tract and affects the thyroid, lungs, heart and kidneys. Cobalt sulfate is mutagenic in mammalian cells and is reasonably anticipated to be a human carcinogen based on evidence of carcinogenicity in experimental animals. (NCI05) ( NCI )] (UMLS (NCI) C0056026) =Hazardous or Poisonous Substance; Inorganic Chemical ;
|
- 14. C6orf49
- [Encoded by human OBTP Gene, 74-amino acid 8 kD Over-Expressed Breast Tumor Protein contains two LIM domains and may mediate protein-protein interactions. (from SWISS-PROT, and NCI) ( NCI )] (UMLS (NCI) C1335080) OBTP Protein;
Over-Expressed Breast Tumor Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 64. cobamide
- [biologically active form of vitamin B12, in which the cyanide counterion has been replaced by an adenine nucleoside. ( CSP )] (UMLS (CSP) C0009156) =Organic Chemical; Pharmacologic Substance; Vitamin =adenosylcobalamin;
|
- 15. C9orf19
- [This gene plays a role in the immune response. ( NCI )] (UMLS (NCI) C1425234) C9orf19 Gene;
Chromosome 9 Open Reading Frame 19 Gene =Gene or Genome | - 65. Cobb's Syndrome
- (UMLS (NCI) C0346068) =Congenital Abnormality
|
- 16. Co
- [trace element that is a component of vitamin B12; atomic symbol Co, atomic number 27, and atomic weight 58.93. ( CSP )] (UMLS (NCI) C0009148) =Biologically Active Substance; Element, Ion, or Isotope ;
=Micronutrient;
heavy metal =COBALT,CO-57;
| - 66. COCA 1
- [HNPCC with no history of associated cancers. ( MSH )] (UMLS (NCI) C1333990) Familial Non-Polyposis Colon Cancer Type 1;
Hereditary Non-Polyposis Colon Cancer Type 1;
HNPCC1;
Lynch 1 Syndrome;
=Neoplastic Process ;
|
- 17. CO
- [South American country bordering on Caribbean Sea and the Pacific Ocean. ( CSP )] (UMLS (NCI) C0009367) =Geographic Area =South America;
◊ [A state in the Rocky Mountains of western United States. Its capital is Denver. ( NCI )] (UMLS (NCI) C0009399) Geographic Area ; | - 67. COCA 2
- [HNPCC associated with other malignancies, more commonly of ovarian or uterine origin. ( MSH )] (UMLS (NCI) C1333991) Familial Non-Polyposis Colon Cancer Type 2;
Hereditary Non-Polyposis Colon Cancer Type 2;
HNPCC2;
Lynch 2 Syndrome;
=Neoplastic Process ;
|
- 18. Co-Immunoprecipitation
- [Co-immunoprecipitation (Co-IP) is a popular technique for protein interaction discovery. In a co-IP the target antigen precipitated by the antibody "co-precipitates" a binding partner/protein complex from a lysate. It is assumed that these proteins are related to the function of the target antigen at the cellular level. ( NCI )] (UMLS (NCI) C1449705) =Laboratory Procedure ;
| - 68. COCA2
- [MutL Homolog 1 (MLH1), a 84-kD protein encoded by the MLH1 gene, is part of the multi-subunit BASC complex, which may sense abnormal DNA structures and regulate post-replication repair and mismatch repair. Heterodimeric MLH1 Protein and PMS2 provide repair proficiency on heteroduplex DNAs, as well as insertion/deletion mispairs. MLH1 and MLH3 also heterodimerize. Widely expressed, several alternative splice variants occur in diverse tissue types. Some variants lack exons 6/9, 9, 9/10, 9/10/11, 10/11, 12, 16, or 17. Associated with colon, endometrial, and stomach cancers, the defects in MLH1 are a cause of hereditary non-polyposis colorectal cancer. (NCI) ( NCI )] (UMLS (NCI) C0753876) DNA Mismatch Repair Protein MLH1;
FCC2;
hMLH1 Protein;
HNPCC;
HNPCC2;
MGC5172;
Mismatch DNA Repair Protein MLH1;
Mismatch Repair Protein MLH1;
MLH1;
MLH1 Gene Product;
MLH1 Protein;
MUTL Protein Homolog 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 19. co-insurance
- [The covered party pays a percentage of the cost of covered services. ( HL7V3.0 )] (UMLS (HL7) C1555681) =Intellectual Product =ActInvoiceDetailGenericAdjudicatorCode;
| - 69. cocaethylene
- [ ] (UMLS (CSP) C0082060) =Organic Chemical; Pharmacologic Substance ;
|
- 20. Co-payment
- (UMLS (HL7) C0680272) =Quantitative Concept =Transaction Type;
| - 70. cocaine
- [alkaloid ester extracted from the leaves of plants including coca; has powerful central nervous system effects similar to the amphetamines and is a drug of abuse; acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake; it is also a local anesthetic and vasoconstrictor and is clinically used for that purpose. ( CSP )] (UMLS (CSP) C0009170) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance =alkaloid;
[CN800] CNS STIMULANTS;
local anesthetic;
tropane;
Dopamine Agonist;
[NT300] ANESTHETICS, MUCOSAL =crack cocaine;
COCAINE HYDROCHLORIDE |
- 21. coA
- [coenzyme that takes part in fatty acid metabolism. ( CSP )] (UMLS (CSP) C0009226) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=cofactor;
=acyl coA;
| - 71. Cocaine abuse
- (UMLS (ICD9CM) C0009171) =Mental or Behavioral Dysfunction
|
- 22. coA analog
- [ ] (UMLS (CSP) C0598189) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
| - 72. Cocaine abuse, continuous use
- [ ] (UMLS (ICD9CM) C0154533) =Mental or Behavioral Dysfunction
|
- 23. coA transferase
- [Enzymes which transfer coenzyme A moieties from acyl- or acetyl-CoA to various carboxylic acceptors forming a thiol ester. Enzymes in this group are instrumental in ketone body metabolism and utilization of acetoacetate in mitochondria. EC 2.8.3. ( MSH )] (UMLS (CSP) C0009228) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 73. Cocaine abuse, episodic use
- [ ] (UMLS (ICD9CM) C0154534) =Mental or Behavioral Dysfunction
|
- 24. COAd/CO-5
- (UMLS (NCI) C0104713) =Therapeutic or Preventive Procedure
| - 74. Cocaine abuse, in remission
- [ ] (UMLS (ICD9CM) C0154535) =Mental or Behavioral Dysfunction
|
- 25. COAG FACTOR TRANSFUSION
- [ ] (UMLS (ICD9CM) C0199967) =Therapeutic or Preventive Procedure
| - 75. Cocaine Addiction
- (UMLS (NCI) C0600427) =Mental or Behavioral Dysfunction
|
- 26. coagulant
- [Exogenous substances used to promote blood coagulation. The endogenous BLOOD COAGULATION FACTORS are considered to be coagulants only when administered as drugs. ( MSH )] (UMLS (CSP) C0009117) =Pharmacologic Substance
| - 76. Cocaine affecting fetus via placenta or breast milk
- [ ] (UMLS (ICD9CM) C0158812) =Disease or Syndrome
|
- 27. Coagulase-Positive Staphylococcus
- [A subtype of Staphylococcus characterized by an ability to produce free plasma coagulase. ( NCI )] (UMLS (NCI) C1265293) =Bacterium
| - 77. COCAINE DEPEND-CONTIN
- [ ] (UMLS (ICD9CM) C0338762) =Mental or Behavioral Dysfunction
|
- 28. COAGULAT DEFECT NEC/NOS
- [ ] (UMLS (ICD9CM) C0029496) =Disease or Syndrome
| - 78. Cocaine dependence, episodic use
- [ ] (UMLS (ICD9CM) C0338763) =Mental or Behavioral Dysfunction
|
- 29. Coagulation
- [Coagulation ( HL7V3.0 )] (UMLS (HL7) C1561952) =Health Care Activity =ObservationMethod;
| - 79. Cocaine dependence, in remission
- [ ] (UMLS (ICD9CM) C0154487) =Mental or Behavioral Dysfunction
|
- 30. Coagulation (DIC), disseminated intravascular
- [disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels; the activation of the clotting mechanism may arise from any of a number of disorders; in the late stages, it is marked by profuse hemorrhaging. ( CSP )] (UMLS (NCI) C0012739) =Disease or Syndrome =blood coagulation disorder;
HEMORRHAGIC COND NOS;
Thrombophilia;
| - 80. cocaine receptor
- [ ] (UMLS (CSP) C0056053) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 31. Coagulation clinic
- (UMLS (HL7) C1552771) =Intellectual Product ;
=Outpatient facility;
| - 81. Cocal virus
- [ ] (UMLS (CSP) C0544231) =Virus
|
- 32. COAGULATION DEF-ANTEPART
- [ ] (UMLS (ICD9CM) C1719583) Coagulation defects complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication =Disease or Syndrome
| - 82. cocarboxylase
- [biologically active form of thiamin and a cofactor for many oxidative decarboxylation reactions in carbohydrate metabolism. ( CSP )] (UMLS (CSP) C0039848) =Organic Chemical; Pharmacologic Substance; Vitamin =diphosphate;
cofactor |
- 33. COAGULATION DEF-DELIV
- [ ] (UMLS (ICD9CM) C1719581) Coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition =Disease or Syndrome
| - 83. cocarcinogen
- [agent that increases the risk of neoplasms in combination with other factors. ( CSP )] (UMLS (CSP) C0178554) =Pathologic Function ;
=Cancer Causing Agents;
|
- 34. Coagulation defects complicating pregnancy, childbirth, or the puerperium
- [ ] (UMLS (ICD9CM) C1719585) =Disease or Syndrome
| - 84. Coccidia
- [subclass of protozoans commonly parasitic in epithelial cells of the intestinal tract but also found in the liver and other organs; organisms are found in both vertebrates and higher invertebrates and comprise three orders: Eimeriida, Eucoccidiida and Lankesterellidae. ( CSP )] (UMLS (CSP) C0009182) =Invertebrate =Apicomplexa;
=Toxoplasma;
Cyclospora;
Cryptosporidium;
|
- 35. Coagulation defects complicating pregnancy, childbirth, or the puerperium, delivered, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C1719582) COAGULATN DEF-DEL W P/P =Disease or Syndrome
| - 85. COCCIDIOIDAL MENINGITIS
- [ ] (UMLS (ICD9CM) C0153259) =Disease or Syndrome
|
- 36. Coagulation defects complicating pregnancy, childbirth, or the puerperium, postpartum condition or complication
- [ ] (UMLS (ICD9CM) C1719584) COAGULATION DEF-POSTPART =Disease or Syndrome
| - 86. Coccidioides immitis
- [mitosporic fungal species which causes coccidiodomycosis. ( CSP )] (UMLS (CSP) C0009184) =Fungus =mitosporic Ascomycota;
|
- 37. Coagulation defects complicating pregnancy, childbirth, or the puerperium, unspecified as to episode of care or not applicable
- [ ] (UMLS (ICD9CM) C1719580) COAGULATION DEF-UNSPEC =Disease or Syndrome
| - 87. coccidioidomycosis
- [infection with a fungus of the genus Coccidioides, species C. immitis; primary form is an acute, benign, self limited respiratory infection due to inhalation of spores and varying in severity; secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. ( CSP )] (UMLS (CSP) C0009186) =Disease or Syndrome =Fungal Infection;
|
- 38. Coagulation Factor Deficiency
- (UMLS (NCI) C0849773) =Disease or Syndrome
| - 88. coccidiosis
- [protozoan infection found in animals and man; caused by several different genera of Coccidia. ( CSP )] (UMLS (CSP) C0009187) =Disease or Syndrome =INTESTIN PARASITISM NOS;
protozoal infection =cryptosporidiosis;
MALARIA;
Sarcocystosis;
TOKSOPLASMOOSI;
Isosporiasis;
CYCLOSPORIASIS |
- 39. Coagulation Factor Gene
- [Coagulation Factor Genes encode endogenous Coagulation Factors, involved in blood coagulation. (NCI) ( NCI )] (UMLS (NCI) C1333075) =Gene or Genome ;
| - 89. Coccygeal
- (UMLS (HL7) C1550233) =Body Part, Organ, or Organ Component =Body Part;
|
- 40. coagulation factor I
- [plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds; fibrinogen clotting is a sol-gel change involving complex molecular arrangements. ( CSP )] (UMLS (CSP) C0016006) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=acute phase protein;
Blood Coagulation Factor;
Protein Precursors;
=FIBRINOGEN,I-125 | - 90. Coccygeal Body Neoplasm
- (UMLS (NCI) C0474821) =Neoplastic Process
|
- 41. coagulation factor II
- [plasma protein precursor of thrombin, converted to thrombin by a prothrombin activator complex; deficiency of prothrombin leads to hypoprothrombinemia. ( CSP )] (UMLS (CSP) C0033706) =Amino Acid, Peptide, or Protein; Biologically Active Substance =proenzyme;
| - 91. Coccygeal Muscle
- (UMLS (NCI) C0448424) =Body Part, Organ, or Organ Component
|
- 42. Coagulation Factor II (Thrombin) Receptor Gene
- [This gene is involved in coagulation and proteolytic cleavage regulation. ( NCI )] (UMLS (NCI) C1366449) F2R;
F2R Gene =Gene or Genome | - 92. Coccygeal Nerve
- (UMLS (NCI) C0228967) =Body Part, Organ, or Organ Component
|
- 43. Coagulation Factor II Receptor
- [Expressed in platelets and vascular endothelia by human F2R Gene (GPCR1 Family), 425-aa 47-kDa (precursor) Coagulation Factor II Receptor is a 7-transmembrane G-protein coupled high affinity activated thrombin receptor that stimulates phosphoinositide hydrolysis in the cellular thrombotic response. F2R appears to play a role in platelet activation and vascular development. Receptor phosphorylation probably mediates desensitization prior to uncoupling and internalization. Activated protein C uses EPCR as a coreceptor for cleavage of Coagulation Factor II Receptor on endothelia. Proteolytic cleavage of F2R generates a new N-terminus that functions as a tethered ligand. (NCI) ( NCI )] (UMLS (NCI) C0668084) =Amino Acid, Peptide, or Protein; Receptor ;
| - 93. Coccygeal Vertebra
- (UMLS (NCI) C0223616) =Body Part, Organ, or Organ Component
|
- 44. Coagulation Factor III (Thromboplastin, Tissue Factor) Gene
- [This gene is involved in the blood coagulation process by initiating blood coagulation cascades. ( NCI )] (UMLS (NCI) C1333522) F3;
F3 Gene =Gene or Genome | - 94. Coccyx
- (UMLS (HL7) C0009194) =Body Part, Organ, or Organ Component =Body Part;
|
- 45. Coagulation Factor IX (Plasma Thromboplastic Component, Christmas Disease, Hemophilia B) Gene
- [This gene plays a role in the regulation of blood coagulation and is modulated by Ca+2 ions, membrane phospholipids, and factor VIII. ( NCI )] (UMLS (NCI) C1366464) F9;
F9 Gene =Gene or Genome ;
| - 95. Coccyx Fracture
- (UMLS (NCI) C0149860) =Injury or Poisoning
|
- 46. Coagulation Factor VII (Serum Prothrombin Conversion Accelerator) Gene
- [This gene plays an essential role in the maintenance of cellular homeostasis. ( NCI )] (UMLS (NCI) C1333523) F7;
F7 Gene =Gene or Genome | - 96. CochimiYuman
- (UMLS (HL7) C1698052) =Language ;
=Hokan;
=Yuman;
|
- 47. Coagulation Factor VIII, Procoagulant Component (Hemophilia A) Gene
- [This gene plays an important role in blood coagulation. ( NCI )] (UMLS (NCI) C1366370) F8;
F8 Gene =Gene or Genome | - 97. cochlea
- [part of the internal ear that is concerned with hearing; forms the anterior part of the labyrinth, is conical, and is placed almost horizontally anterior to the vestibule. ( CSP )] (UMLS (CSP) C0009195) =Body Part, Organ, or Organ Component =Inner Ear;
|
- 48. coagulation factor XII
- [Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. ( MSH )] (UMLS (CSP) C0015525) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Blood Coagulation Factor;
Serine Endopeptidases | - 98. Cochlear Duct
- [A spiral tube that is firmly suspended in the bony shell-shaped part of the cochlea. This ENDOLYMPH-filled cochlear duct begins at the vestibule and makes 2.5 turns around a core of spongy bone (the modiolus) thus dividing the PERILYMPH-filled spiral canal into two channels, the SCALA VESTIBULI and the SCALA TYMPANI. ( MSH )] (UMLS (NCI) C1323110) =Body Part, Organ, or Organ Component; ;
|
- 49. coagulation factor XIII
- [fibrin-stabilizing plasma transglutaminase that is activated by thrombin and calcium to form factor XIIIa; important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. ( CSP )] (UMLS (CSP) C0015528) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =Blood Coagulation Factor;
| - 99. Cochlear Labyrinth
- (UMLS (NCI) C0931689) =Body Part, Organ, or Organ Component
|
- 50. coal
- [natural fossil fuel formed by partial decomposition of vegetable matter under certain environmental conditions. ( CSP )] (UMLS (CSP) C0009131) =Organic Chemical =fossil fuel energy;
| - 100. cochlear lesion
- [pathological or traumatic discontinuity of the cochlea or loss of function of the cochlea. ( CSP )] (UMLS (CSP) C0596347) =Disease or Syndrome ;
=Labyrinth Diseases;
|
home
